Literature DB >> 2299677

Body fat distribution and breast cancer in the Framingham Study.

R Ballard-Barbash1, A Schatzkin, C L Carter, W B Kannel, B E Kreger, R B D'Agostino, G L Splansky, K M Anderson, W E Helsel.   

Abstract

We examined the relation between central body fat distribution and breast cancer in a prospective cohort of women who participated in the Framingham Study. At the baseline examination in 1948, a total of 2,201 women aged 30-62 years were analyzed. An index of central to peripheral body fat (the central adiposity ratio) was calculated from the sum of the trunkal skinfolds (chest, subscapular, and abdominal) divided by the sum of the extremity skinfolds (triceps and thigh). These skinfolds were measured at the fourth examination in 1954. The cohort was followed for up to 28 years and yielded 106 cases of breast cancer. When divided into quartiles based on the central adiposity ratio, only women in the fourth quartile (those with the highest central to peripheral body fat distribution) demonstrated an increased risk for breast cancer. The age- and adiposity-adjusted relative risk estimate for having an increased central adiposity ratio (fourth quartile) compared to lower central adiposity ratios was 1.8 (95% confidence interval, 1.2-2.6). Adjustment for potential confounders of height, parity, and education did not appreciably alter this estimate (1.7, 1.1-2.5). There was no association between degree of adiposity, as measured by the sum of the five skinfolds or by body mass index (weight in kg divided by height in m2), and subsequent breast cancer. The results of this study suggest that increased central to peripheral body fat distribution predicts breast cancer risk independently of the degree of adiposity and may be a more specific marker of a premalignant hormonal pattern than degree of adiposity.

Entities:  

Mesh:

Year:  1990        PMID: 2299677     DOI: 10.1093/jnci/82.4.286

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  17 in total

1.  Treatment for morbid obesity.

Authors:  A R Carmichael
Journal:  Postgrad Med J       Date:  1999-01       Impact factor: 2.401

Review 2.  Breast cancer hypothesis: a single cause for the majority of cases.

Authors:  R A Wiseman
Journal:  J Epidemiol Community Health       Date:  2000-11       Impact factor: 3.710

3.  Body fat distribution in relation to breast cancer in women participating in the DOM-project.

Authors:  I den Tonkelaar; J C Seidell; H J Collette
Journal:  Breast Cancer Res Treat       Date:  1995-04       Impact factor: 4.872

4.  Cardiometabolic factors and breast cancer risk in U.S. black women.

Authors:  Jaclyn L F Bosco; Julie R Palmer; Deborah A Boggs; Elizabeth E Hatch; Lynn Rosenberg
Journal:  Breast Cancer Res Treat       Date:  2012-06-19       Impact factor: 4.872

5.  Obesity and subcutaneous fat patterning in relation to survival of postmenopausal breast cancer patients participating in the DOM-project.

Authors:  I den Tonkelaar; F de Waard; J C Seidell; J Fracheboud
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

6.  Measures of adiposity and body fat distribution in relation to serum folate levels in postmenopausal women in a feeding study.

Authors:  S Mahabir; S Ettinger; L Johnson; D J Baer; B A Clevidence; T J Hartman; P R Taylor
Journal:  Eur J Clin Nutr       Date:  2007-04-25       Impact factor: 4.016

Review 7.  Phytoestrogens, body composition, and breast cancer.

Authors:  P L Horn-Ross
Journal:  Cancer Causes Control       Date:  1995-11       Impact factor: 2.506

Review 8.  Regulation of aromatase expression in human tissues.

Authors:  S E Bulun; E R Simpson
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Loneliness, emotional repression, marital quality, and major life events in women who develop breast cancer.

Authors:  C M Fox; A P Harper; G C Hyner; R M Lyle
Journal:  J Community Health       Date:  1994-12

Review 10.  Nutrition and breast cancer risk: can an effect via insulin resistance be demonstrated?

Authors:  B A Stoll
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.